2 weeks Ago By Defense World Staff
Vanguard Group Inc. decreased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) by 3.
5% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 11,421,710 shares of the company’s stock after selling 419,169 shares during the period. Vanguard Group Inc.
owned 9.52% of Privia Health Group worth $223,294,000 at the end of the most recent reporting period. Several other large investors have also modified their holdings of PRVA.
Riverbridge Partners LLC boosted its position in Privia Health Group by 19.7% during the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock valued at $113,868,000 after purchasing an additional 958,418 shares in the last quarter.
Barclays PLC increased its position in shares of Privia Health Group by 240.3% in the 3rd quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after acquiring an additional 158,188 shares during the period.
Sei Investments Co. raised its stake in Privia Health Group by 26.2% in the 4th quarter.
Sei Investments Co. now owns 573,635 shares of the company’s stock worth $11,215,000 after acquiring an additional 119,052 shares during the last quarter. Victory Capital Management Inc.
lifted its position in Privia Health Group by 62.0% during the 4th quarter. Victory Capital Management Inc.
now owns 290,009 shares of the company’s stock worth $5,670,000 after acquiring an additional 110,960 shares during the period. Finally, Nordea Investment Management AB grew its stake in Privia Health Group by 33.1% during the 4th quarter.
Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after purchasing an additional 86,910 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.
Privia Health Group Trading Down 1.2 %Shares of PRVA opened at $21.97 on Friday.
The firm has a market cap of $2.65 billion, a P/E ratio of 219.72, a PEG ratio of 3.
47 and a beta of 0.88. Privia Health Group, Inc.
has a 12 month low of $15.92 and a 12 month high of $26.04.
The stock’s 50 day moving average is $23.78 and its two-hundred day moving average is $21.31.
Analysts Set New Price TargetsSeveral research analysts have recently issued reports on PRVA shares. Piper Sandler raised their price objective on Privia Health Group from $25.00 to $40.
00 and gave the stock an “overweight” rating in a research note on Friday, February 28th. Canaccord Genuity Group lifted their price objective on shares of Privia Health Group from $29.00 to $30.
00 and gave the company a “buy” rating in a research note on Friday, February 28th. Stephens reaffirmed an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd.
Macquarie initiated coverage on shares of Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 target price for the company.
Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $30.00 price target on shares of Privia Health Group in a report on Friday, March 21st. One investment analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock.
Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $26.67.
Check Out Our Latest Stock Analysis on Privia Health GroupInsider ActivityIn other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the business’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.
40. Following the completion of the sale, the chief financial officer now directly owns 179,676 shares in the company, valued at approximately $4,021,148.88.
The trade was a 3.04 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Insiders own 14.20% of the company’s stock. Privia Health Group Profile (Free Report)Privia Health Group, Inc operates as a national physician-enablement company in the United States.
The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.Read MoreFive stocks we like better than Privia Health GroupStock Market Upgrades: What Are They?Conagra Stock Could Thrive as Tariffs Hit Other SectorsHow to Short a Stock in 5 Easy Steps Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey FindsHow to trade penny stocks: A step-by-step guideSpotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc.
(NASDAQ:PRVA – Free Report)..
